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Background: Today percutaneous intervention is the preferred treatment for athero-
sclerotic disease in any part of the body, therefore there is a greater potential for
embolization of material used on such devices. Several reports have shown that
foreign materials such as the hydrophilic polymer can induce obstruction of small
vessels with distal necrosis as well as granulomatous hypersensitivity reaction
(Modern Pathology 2010; 23:921-30).
Methods: We reviewed autopsy registry ﬁles from 2005 to 2013 and identiﬁed 13
cases of foreign body hydrophilic polymer that was associated with untoward effects.
Results: There were 10 coronary (total stents ¼ 29) and 3 intracerebral interventions
that at autopsy had foreign materials identiﬁed around the stent strut or in the distal
bed. Overlapping stent were used in 6 cases (60%) and mean stented lesion length was
2718mm in the coronary artery cases. All showed the presence of foreign body
basophilic materials in the intramural small coronary artery with or without chronic
inﬂammation, ﬁbrin and giant cells. Foreign body basophilic materials were observed
around stent struts in 3 cases. Basophilic materials were identiﬁed in the left ventricle
in 6 cases (60%), right ventricle in 3 cases (30%) and in both ventricle in 1 case (10%).
Most of the basophilic materials were seen in the epicardial one third of the ventricle
with or without myocyte necrosis. The 3 intracerebral cases involved the internal
carotid artery in 2 and the basilar artery in 1, all had Pipeline stent implantation and in
2 cases embolic material was identiﬁed in the area of the intracerebral hemorrhage
and/or in surrounding brain sections with or without inﬂammation. All 3 Pipeline
stents in the artery showed basophilic material on histologic examination. In some
cases the basophilic material was identiﬁed to be hydrogel on spectroscopic
examination.
Conclusions: Hydrogel polymers are commonly used on interventional devises for
improvement of deliverability. However, unexpectable embolization of basophilic
hydrogel was identiﬁed in all 13 cases. Hydrogel is not a benign material and its use in
its current form on devices should be changed.
TCT-320
The Paclitaxel-coated balloon catheter presents a therapeutic alternative in select
coronary indications – Results of an analysis of the raw data of 7 prospective
studies
Martin Unverdorben1, Hannah Nuiding1, Christian Vallbracht2, Bruno Scheller3,
Ralf Degenhardt1
1Clinical Research Institute, Rotenburg, Germany, 2Center for Cardiovascular
Diseases, Rotenburg, Germany, 3University of Saarland, Germany, Homburg,
Germany
Background: The paclitaxel-coated balloon catheter (DCB) based on the
PACCOCATH technology has yielded angiographic and clinical results superior to
drug-eluting stents in situations like bare-metal in-stent restenosis and a trend towards
better outcome in small coronary vessels and side branches of coronary bifurcations.
The sample size of each individual study, however, was relatively small
Methods: To strengthen the evidence, the raw data of all 401 patients (63.310.5
years, 74.3% men) with 446 stenoses that were treated with SeQuentTM Please DCB
or its predecessor in the PACCOCATH ISR I/II, PEPCAD I, II, IV, V and INDICOR
studies were analyzed. Main outcome parameters encompassed the 6-9month angio-
graphic and 1-year MACE data. The patients were categorized into the following
groups: De-novo lesions in native vessels treated with DCBonly (82Px./106 stenoses),
stenoses in native vessels treated with DCB and several types of bare-metal stents
(BMS) (DCB+BMS: 202Px. /223 stenoses) and bare-metal in-stent restenosis treated
with DCB only (BMS-ISR; 117Px./117 stenoses).
Results: DCBonly compared to BMS-ISR did not show statistically different results
for late lumen loss (LLL) (0.190.59mm vs 0.230.53mm), LLLIndex (0.150.31B102 JACC Vol 62/18/Suppl B j October 27–Novemvs 0.160.56), target lesion revascularization (TLR) (4/82 (4.9%) vs 6/117 (5.1%)),
lesion related myocardial infarction major and target lesion thrombosis (both
parameters in both groups 0), cardiac death (0/82 (0%) vs 1/117 (0.9%)), and major
adverse cardiac events (MACE) (4/82 (4.9%) vs 6/117 (5.1%)). In DCB combined
with BMS, TLR (16/202 (7.9%)), lesion related myocardial infarction (7/202 (3.5%)),
target lesion related thrombosis (5/202 (2.5%)), and cardiac death (3/202 (1.5%)) were
statistically not different compared to DCB only in de-novo lesions while in
DCB+BMS the LLL (0.550.65mm) was signiﬁcantly (p<0.001) greater as were
LLLIndex (0.340.41, p<0.001) and MACE 25/202 (12.4%) (p¼0.08). The 1-year
MACE rates were independent from gender, and the cardiovascular risk factors
smoking, hyperlipidemia, obesity, hypertension, and diabetes.
Conclusions: Angiographically, DCBonly was superior to its combination with bare
metal stents whereas MACE data trended superior.
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Background: Prior studies implicated that a longer diabetes duration might raise
coronary artery disease (CAD) risks and predict mortality. However, few studies have
addressed its predictive value in patients undergoing coronary revascularization. Thus,
we aimed to evaluate the impact of diabetes duration on long-term clinical outcomes
after primary percutaneous coronary intervention (PCI) or coronary artery bypass
grafting (CABG).
Methods: A total of 820 diabetic patients treated for stable CAD were consecutively
included in this retrospective single-center study. With a median follow-up of 3.5
years, patients’ outcomes were assessed by major adverse cardiac events (MACEs)
and the incidence of nonfatal stroke. MACEs were deﬁned as the need for revascu-
larization, non-fatal myocardial infarction, or cardiovascular death.
Results: At 3-year follow-up, MACE rate was signiﬁcantly higher in PCI- compared
with CABG-treated patients (13.30% vs. 7.02%, p¼0.001). Multivariate Cox
regression analysis revealed that a longer diabetes duration ( 5 years) was an
independent predictor for the incidence of MACEs after PCI (HR¼1.89, 95% CI 1.08-
3.30, p¼0.03), but not CABG (0.21-2.93, p¼0.73). In addition, while CABG was
superior to PCI in patients with diabetes duration  5 years (17.30% vs. 7.21%,
p¼0.003), no difference was observed in those < 5 years (9.36% vs. 6.86%, p¼0.18).
Notably, no differential treatment effect according to the category of SYNTAX score
was found in patients with diabetes duration < or  5 years (p¼0.79 and p¼0.15,
respectively). In contrast to MACEs, nonfatal stroke was more frequent in CABG-
than PCI-treated patients (4.36% vs. 1.13% p¼0.02), with no signiﬁcant interaction
between diabetes duration and treatment strategies on the outcome (p¼0.58).
Conclusions: For stable CAD patients with a longer diabetes duration ( 5 years),
CABG was superior to PCI in that it signiﬁcantly reduced rates of MACEs, despite of
a higher rate of nonfatal stroke. However, for those with a shorter diabetes duration
(< 5 years), PCI was more preferable than CABG, which was independent of the
SYNTAX stratiﬁcation, as it markedly reduced rate of nonfatal stroke without
signiﬁcantly increasing the risk of MACEs.
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Background: Both diabetes mellitus (DM) and incomplete revascularization (IR) are
associated with a poor prognosis after percutaneous coronary intervention (PCI). We
sought to quantify the extent and impact of IR following PCI using the residual
SYNTAX score (rSS) in patients (pts) with and without DM.
Methods: The rSS was determined by an angiographic core laboratory in 2672 pts
with moderate and high-risk acute coronary syndromes (ACS) undergoing PCI from
the ACUITY trial. Pts were stratiﬁed by rSS tertiles. A rSS¼0 was deﬁned as
complete revascularization (CR). One-year major adverse cardiovascular events
(MACE) according to rSS were examined in DM and non-DM pts.
Results: Overall, 770 (28.8%) pts had DM and 1,902 did not. The mean rSS was
4.96.6 and 4.16.5 in DM and non-DM pts respectively (p¼0.004). CR was ach-
ieved in 35.0% of DM and 42.5% of non-DM pts (p¼0.004). As rSS increased, 1-year
MACE was signiﬁcantly higher in non-DM but not DM pts (Figure). DM pts also had
higher incidence of death (3.0% vs.0.9%; p¼0.01) and MACE at 1-year (22.5% vs.
14.1%; p¼0.001) than non-DM pts, even when CR was achieved.ber 1, 2013 j TCT Abstracts/POSTER/Miscellaneous Coronary Topics
